Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
LOADING
|||
Analyst Sentiment
Analysts are neutral — opinion is divided on direction.
Consensus Rating
Hold
29 analysts·High coverage
38%
Rating Distribution
Strong Buy
00%
Buy
1138%
Hold
1552%
Sell
310%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Analysts see modest upside — consensus target 9% higher.
Bear Case
$5.00
+2%
Consensus
$5.35
+9%
Bull Case
$5.70
+17%
Price Range29 analysts
Low
Consensus
High
$5.00
$5.70
Current Target
Current Price
$4.89
Upside to Target
$0.46
Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.